FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacology and medicine, and represents a solid and stable oral dispersion of water-soluble Vinca alkaloid derivative, particularly vinorelbine in at least one polyethylene glycol of molecular weight within 1000 and 6000, wherein a mass ratio of water-soluble vinorelbine and more specifically, firstly vinorelbine ditartrate and, secondly polyethylene glycol is within 1.5:1 and 1:10 and, preferentially within 1:3 and 1:6.
EFFECT: invention provides higher stability of Vinca alkaloid derivatives, and especially vinorelbine salts, particularly vinorelbine ditartrate.
14 cl, 3 ex, 2 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
| STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
| VINORELBIN-CONTAINING ORAL PHARMACEUTICAL COMPOSITION FOR SOFT CAPSULE AND METHOD FOR TREATMENT | 2003 |
|
RU2279873C2 |
| VINORELBINE MONOTARTRATE AND ITS PHARMACEUTICAL APPLICATION | 2016 |
|
RU2730521C2 |
| LYOPHILISED INJECTED PHARMACEUTICAL COMPOSTION OF SEMISYNTHETIC ALKALOIDS VINCA AND CARBOHYDRATES, STABLE AT ROOM TEMPERATURE | 2007 |
|
RU2449791C2 |
| SOLID DISPERSION OF CINNARIZINE | 2021 |
|
RU2776962C1 |
| NEW PHARMACEUTICAL COMPOSITION OF TAMSULOZIN AND DUTASTERIDE | 2019 |
|
RU2795928C2 |
| ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION | 2003 |
|
RU2314811C2 |
| DOSAGE FORMS IN FORM OF CAPSULES | 2019 |
|
RU2824998C2 |
| PHARMACEUTICAL COMPOSITION BASED ON INDOMETHACIN MENTHYL ESTER IN FORM OF SOLID SELF-EMULSIFYING SYSTEM | 2023 |
|
RU2823982C1 |
